SyloSpace

Do hearing aids lower the risk of dementia?

Hearing loss is linked to faster cognitive decline and higher dementia risk, but trials of hearing aids show mixed results.

Updated 4 hours ago5 min readVersion 2
CommentsFollow

Covers: This page covers the evidence linking hearing loss to dementia risk and whether using hearing aids reduces that risk. It does not cover other treatments for dementia or the mechanisms of hearing loss.

3 free full reads left this month. Join or upgrade

A single human ear isolated on a plain white background
Photo: Franco Antonio Giovanella

The short answer

Interpretation AI-prepared starting map

Hearing loss is consistently associated with accelerated cognitive decline and higher dementia risk, but the trial evidence on whether hearing aids reduce that risk is mixed. In older adults with mild cognitive impairment and hearing loss, a hearing-aid intervention did not significantly reduce conversion to dementia-level impairment at 24 months (3.09% vs 4.74%; risk difference -2.07%, 95% CI -4.74% to 0.61%; RR 0.59, 95% CI 0.25-1.38; P = .23), while a prespecified secondary analysis found a large increase in cognitive improvement (15.34% vs 2.36%; RR 5.94, 95% CI 2.46-14.37). A secondary analysis of the ACHIEVE trial found hearing intervention was associated with a slower three-year rise in GFAP, a neuroinflammation biomarker (difference -0.175, 95% CI -0.322 to -0.028; p = 0.019), with a comparable but non-significant trend for NfL.123

What this rests on5 independent sources
  • Evidence 18
  • Interpretation 5

In brief

  1. Hearing loss is consistently linked to faster cognitive decline and higher dementia risk, but the causal pathway is not fully understood.2

    Evidence-backed
  2. In the CHOICE trial, hearing aids did not significantly reduce conversion to dementia-level impairment at 24 months, though the confidence interval was wide.1

    Evidence-backed
  3. The same trial found a large increase in cognitive improvement among hearing-aid users in a secondary analysis.1

    Evidence-backed
  4. An ACHIEVE secondary analysis found hearing intervention slowed the rise of a neuroinflammation biomarker (GFAP) over three years, with a non-significant trend for a neurodegeneration marker (NfL).3

    Evidence-backed
  5. Cognitive benefit from hearing aids may depend on the listener's working memory and on device fitting, not just on amplification.4

    Interpretation

At a glance

The picture in numbers

Live · updated just now

Prespecified secondary analysis of the CHOICE trial
  • Hearing-aid group15.3%
  • Control group2.4%
of older adults with mild cognitive impairment and hearing loss who showed cognitive improvement1
Mean age 78.1 years; 64.0% female

164 participants

164 participants: participants in the ACHIEVE biomarker secondary analysis3
Blood markers of neuroinflammation and neurodegeneration

3 years

3 years: years of biomarker follow-up in the ACHIEVE secondary analysis

The evidence behind it

5 sources
  • Reviews of many studies1
  • Trials2
  • Other studies and data1
  • Background1

Published in 2026

Sources on this page by kind and year
SourceKindYear
Hearing Intervention for Older Adults With Mild Cognitive Impairment: The CHOICE Randomized Clinical Trial.Trials2026
Hearing Loss, Cognitive Decline, and Dementia: Clinical Intersections.Other studies and data2026
Speech Perception in Noise: A Narrative Review of Cognitive Contribution and Hearing-Aid Signal Processing.Reviews of many studies2026
Effects of hearing intervention on blood-based biomarkers of neuroinflammation and neurodegeneration: a secondary analysis of the ACHIEVE randomised controlled trial.Trials2026
Hearing loss (Wikipedia)BackgroundUnknown

The community around it

Contributions
0
People
0
Following
0

Nobody has added anything yet. Experience, evidence or a different view would show up here.

What it means for you

Which fits you?

Pick the situation closest to yours. Each answer says what it rests on.

If you have hearing loss and are worried about dementia risk

the evidence is mixed: hearing aids did not significantly reduce conversion to dementia-level impairment at 24 months in the CHOICE trial, but were linked to more cognitive improvement and to slower rise of a neuroinflammation biomarker. Discuss hearing assessment with a clinician rather than treating aids as a proven dementia preventive.13

Interpretation

If you have mild cognitive impairment and coexisting hearing loss

this is the group studied in the CHOICE trial, where hearing aids did not significantly change dementia-level conversion at 24 months but did increase cognitive improvement in a secondary analysis.1

Evidence-backed

If you are being assessed for cognitive problems

ask whether your hearing has been tested, because unrecognised hearing impairment can affect cognitive test performance and diagnostic accuracy.2

Evidence-backed

If you struggle to hear in noisy places and rely on working memory to follow speech

hearing-aid benefit may depend on your working memory, and some signal-processing features such as fast-acting compression and frequency lowering may be counterproductive for listeners with reduced working memory or speech processing.4

Evidence-backed

If you are older and have age-related hearing loss affecting both ears

this pattern is usually due to cochlear hair cell loss and can contribute to isolation and loneliness, one of the proposed routes linking hearing loss to cognitive outcomes.5

Evidence-backed

The full story · 4 chapters

01

Hearing loss and dementia risk: what the association shows

AI summary:Hearing loss is tied to faster cognitive decline and higher dementia risk, though the reasons are not fully understood.

Evidence-backed

Evidence-backed: Accumulating evidence indicates that hearing loss is associated with accelerated cognitive decline and increased dementia risk. Proposed mechanisms include increased cognitive load, reduced sensory input, social isolation, depression, and shared neurodegenerative or vascular pathology, although causal pathways remain incompletely understood.2

Evidence-backed

Evidence-backed: Hearing loss related to age usually affects both ears and is due to cochlear hair cell loss. In some people, particularly older people, hearing loss can result in isolation and loneliness — one of the proposed routes linking hearing loss to cognitive outcomes.5

Evidence-backed

Evidence-backed: Unrecognised hearing impairment may also influence cognitive test performance, communication, and diagnostic accuracy, which matters when interpreting studies that measure cognition in people with hearing loss.2

02

Do hearing aids change the risk? Trial evidence

AI summary:In the CHOICE trial, hearing aids did not significantly reduce conversion to dementia-level impairment, but a secondary analysis found more cognitive improvement.

Evidence-backed

Evidence-backed: In the CHOICE randomised trial, older adults with mild cognitive impairment and coexisting hearing loss received a hearing-aid intervention. The primary outcome — conversion from MCI to dementia-level impairment at 24 months — did not differ significantly between groups: 3.09% (95% CI 1.62%-5.74%) in the intervention group vs 4.74% (95% CI 2.60%-8.29%) in the control group (risk difference -2.07%, 95% CI -4.74% to 0.61%; RR 0.59, 95% CI 0.25-1.38; P = .23). No study-related adverse events were reported.1

Evidence-backed

Evidence-backed: A prespecified secondary analysis of the same trial found that hearing intervention increased the rate of cognitive improvement: 15.34% (95% CI 11.84%-19.62%) vs 2.36% (95% CI 0.99%-5.22%); risk difference 12.00% (95% CI 8.79%-15.21%); RR 5.94 (95% CI 2.46-14.37).1

Evidence-backed

Evidence-backed: A secondary analysis of the ACHIEVE randomised controlled trial measured blood-based biomarkers over three years in 164 participants (mean age 78.1 years, 64.0% female, 73.2% White). Hearing intervention was associated with a slower rise in GFAP, a marker of neuroinflammation (intervention -0.026, 95% CI -0.144 to 0.093; control 0.149, 95% CI 0.039 to 0.260; difference -0.175, 95% CI -0.322 to -0.028; p = 0.019). A comparable estimate was seen for NfL, a neurodegeneration marker (difference -0.159, 95% CI -0.348 to 0.029; p = 0.098), but it was not statistically significant.3

Interpretation

Interpretation: The biomarker authors interpret their findings as suggesting that hearing intervention may reduce the rate of change in non-specific blood-based biomarkers associated with brain health and dementia progression.3

03

Why hearing aids might matter: cognitive processing

AI summary:Cognitive benefit from hearing aids may depend on the listener's working memory and how the device is fitted, not just amplification.

Evidence-backed

Evidence-backed: Within the Ease of Language Understanding (ELU) model, degraded acoustic input shifts processing from rapid, implicit lexical access toward explicit working-memory-dependent reconstruction. Working memory in particular may predict aided speech recognition under adverse conditions, and aging dissociates these processes. Longitudinal studies link hearing-aid use to slower cognitive decline.4

Evidence-backed

Evidence-backed: The same review notes that fast-acting compression and frequency lowering may be counterproductive for listeners whose working memory or speech processing is reduced, and that the success of hearing-aid signal-processing algorithms in noisy settings depends on working memory.4

Interpretation

Interpretation: Taken together, this suggests the cognitive benefit of hearing aids may not be uniform: it could depend on the listener's working memory and on how the device is fitted, rather than on amplification alone.42

04

What this means for assessment and management

AI summary:Evidence supports including hearing assessment in cognitive care and research, though hearing rehabilitation findings remain mixed.

Evidence-backed

Evidence-backed: Current evidence supports hearing loss as an important factor in cognitive aging and dementia research and highlights the potential value of integrating hearing assessment and management into clinical and research settings. Emerging evidence suggests hearing rehabilitation may help preserve cognitive function in some groups, but findings remain heterogeneous.2

Evidence-backed

Evidence-backed: Because unrecognised hearing impairment can affect cognitive test performance and diagnostic accuracy, considering auditory function during cognitive assessment is supported by the clinical literature.2

Ask this Sylo

Still wondering about something?

Answers come only from this page's reviewed material, with citations, and say plainly when the page doesn't cover it yet.

Behind this page

Who's adding to it, where it comes from, how it changed and what would make it better. Always open to everyone.

Discussion

Nobody has added anything yet. If you have experience, evidence or a different view, you could be the first.

Sources

Numbers match the citations in the article. A working link isn't proof that a page supports a claim; check the quoted passage and date.

  1. 1
    Hearing Intervention for Older Adults With Mild Cognitive Impairment: The CHOICE Randomized Clinical Trial.
    JAMA neurology (Chen et al.)Published Sep 28, 2026Checked Oct 4, 2026
    “No significant difference was observed in the primary outcome, in which the conversion rate from MCI to dementia-level impairment was 3.09% (95% CI, 1.62%-5.74%) in the intervention group vs 4.74% (95% CI, 2.60%-8.29%) in the control group (risk difference [RD], -2.07%; 95% CI, -4.74% to 0.61%; relative risk [RR], 0.59; 95% CI, 0.25-1.38; P = .23). Meanwhile, prespecified secondary analysis demonstrated that hearing intervention increased the rate of cognitive improvement (15.34%; 95% CI, 11.84%-19.62% vs 2.36%; 95% CI, 0.99%-5.22%; RD, 12.00%; 95% CI, 8.79%-15.21%; RR, 5.94; 95% CI, 2.46-14.37). No study-related adverse events were reported.Conclusions and relevanceIn this study, among older adults with mild cognitive impairment and coexisting hearing loss, a hearing aid intervention did not significantly reduce the incidence of dementia-level impairment at 24 months.Trial registrationChinese Clinical Trial Registry Identifier: ChiCTR2000036139.”
  2. 2
    Hearing Loss, Cognitive Decline, and Dementia: Clinical Intersections.
    Audiology research (Powell et al.)Published Jun 30, 2026Checked Oct 4, 2026
    “Accumulating evidence indicates that hearing loss is associated with accelerated cognitive decline and increased dementia risk. Proposed mechanisms include increased cognitive load, reduced sensory input, social isolation, depression, and shared neurodegenerative or vascular pathology, although causal pathways remain incompletely understood. Emerging evidence suggests that hearing rehabilitation may help preserve cognitive function in some groups, but findings remain heterogeneous. Clinical studies further support the importance of considering auditory function during cognitive assessment, as unrecognized hearing impairment may influence test performance, communication, and diagnostic accuracy. Current evidence supports hearing loss as an important factor in cognitive aging and dementia research and highlights the potential value of integrating hearing assessment and management into clinical and research settings.”
  3. 3
    Effects of hearing intervention on blood-based biomarkers of neuroinflammation and neurodegeneration: a secondary analysis of the ACHIEVE randomised controlled trial.
    EClinicalMedicine (Pike et al.)Published Sep 3, 2026Checked Oct 4, 2026
    “Covariate-adjusted linear mixed effects models estimated intention-to-treat effects on 3-year change in inverse-normal transformed values of GFAP and NfL.FindingsParticipants in the analytic sample (n = 164) were mean (SD) age 78.1 (2.9) years, 64.0% female, and 73.2% White. Over three years, hearing intervention was associated with a slower rise in GFAP (intervention: -0.026; 95% CI: -0.144, 0.093, control: 0.149; 95% CI: 0.039, 0.260; difference: -0.175; 95% CI: -0.322, -0.028; p-difference: 0.019) and NfL (intervention: 0.171; 95% CI: 0.022, 0.319, control: 0.330; 95 %CI: 0.185, 0.475, difference: -0.159; 95 %CI: -0.348, 0.029; p-difference: 0.098).InterpretationRandomisation to hearing intervention was associated with a slower three-year rise in a blood-based biomarker of neuroinflammation. Comparable estimates were observed for neurodegeneration, although the effect was not statistically significant. Findings suggest that hearing intervention may reduce the rate of change in non-specific blood-based biomarkers associated with brain health and dementia progression.FundingUS National Institutes of Health.”
  4. 4
    Speech Perception in Noise: A Narrative Review of Cognitive Contribution and Hearing-Aid Signal Processing.
    Journal of Intelligence (Monzani et al.)Published Sep 21, 2026Checked Oct 4, 2026
    “Within the Ease of Language Understanding (ELU) model, this paper describes how degraded acoustic input shifts processing from rapid, implicit lexical access toward explicit working-memory-dependent reconstruction. The actual evidence indicates (i) that working memory, in particular, could predict aided speech recognition under adverse conditions, (ii) that aging dissociates these processes, and (iii) that longitudinal studies link hearing-aid use to slower cognitive decline.ConclusionsSpeech perception in noise is a coordinated neurocognitive process rather than a purely auditory task. Working memory is a central cognitive contributor, with effects that become evident specifically under adverse conditions. In particular, fast-acting compression and frequency lowering may be counterproductive for listeners in case working memory or speech processing are reduced. The success of different algorithms applied to audio signal processing of hearing aid, designed to compensate for difficult comprehension of words and phrases in noisy scenarios is also strictly dependent on working memory, and artificial intelligence significantly contributes to this goal.”
  5. 5
    Hearing loss (Wikipedia)
    WikipediaPublished Oct 4, 2026Checked Oct 4, 2026
    “Hearing loss is either a partial inability to hear, or a total inability termed deafness. Hearing loss may be present at birth or acquired at any time afterwards. Hearing loss may occur in one or both ears. In children, hearing problems can affect the ability to acquire spoken language. In adults, it can create difficulties with social interaction and at work. Hearing loss can be temporary or permanent. Hearing loss related to age usually affects both ears and is due to cochlear hair cell loss. In some people, particularly older people, hearing loss can result in isolation and loneliness. Hearing loss may be caused by a number of factors, including: genetics, ageing, exposure to noise, some infections, birth complications, trauma to the ear or brain, and certain medications or toxins. A common condition that results in hearing loss is chronic ear infections. Certain infections during pregnancy, such as cytomegalovirus, syphilis and rubella, may also cause hearing loss in the child. Hearing loss is diagnosed when hearing testing finds that a person is unable to hear 25 decibels in at least one ear. Testing for poor hearing is recommended for all newborns.”

How it changed

Published 1 time since Oct 4, 2026.

  1. Version 2Oct 4, 2026Live now

    AI-prepared Starting Map from live research.

    • First published version.
Every version, side by side

Help improve it

The brief is open about what's uncertain. These are the specific gaps that new material would fill.

  • “What this means for assessment and management” rests on one independent source

    A second, independent source that confirms or challenges it would make this part more reliable.

Open questions

  • Do the cognitive and biomarker signals seen at 2-3 years translate into fewer dementia diagnoses over longer follow-up?

    No answers yet

  • Which subgroups (by baseline cognition, working memory, degree of hearing loss, or device fitting) gain the most cognitive benefit from hearing aids?

    No answers yet

  • How much of the hearing-loss/dementia association is causal versus driven by shared underlying pathology?

    No answers yet

  • Do the GFAP and NfL changes reflect a real slowing of neurodegeneration, or a non-specific response to treatment?

    No answers yet

Around this topic

Sylos connect: narrower topics report up to broader ones, so what's learned in one place shows up where it matters.

Add what you know

Sign in to add what you know. Reading stays open to everyone.

Ask this Sylo

Answers only from “Do hearing aids lower the risk of dementia?”

Ask anything about this page. The AI reads only its reviewed brief, sources and contributions, cites what it used, and says when the page doesn't cover something.